All Stories

  1. Hepatic zinc deficiency dampens the acute phase response in patients with alcohol-associated hepatitis
  2. Cat viruses as windows into human oncogenesis
  3. Recurrent integration of domestic cat hepatitis B virus DNA near feline CCNE1 supports an oncogenic role in hepatocellular carcinoma in cats
  4. Biology of hepatitis B virus DNA integration and its impact on antiviral R&D
  5. Hepatitis B viral DNA integration occurs within three days of infection and is enhanced by ATR inhibition
  6. Patient and public health perspectives to inform expansion of hepatitis B treatment guidelines
  7. Scientific and medical evidence informing expansion of hepatitis B treatment guidelines
  8. Let's break it down: combating hepatitis stigma and discrimination
  9. Virology special issue: Hepatitis B
  10. Sexual health and young people living with chronic hepatitis B: adopting a treatment as prevention framework
  11. Domestic Cat Hepadnavirus, a Hepatitis B-like Virus Associated with Feline Liver Disease
  12. Demographic factors, knowledge, and experiences associated with engagement in care in Australians diagnosed with hepatitis B
  13. Domestic cat hepadnavirus is detected infrequently in feline blood and liver samples submitted for diagnostic testing in Texas, USA
  14. Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024
  15. Best practices for engaging with affected communities: chronic hepatitis B as a case study
  16. The urgent need to end hepatitis B stigma and discrimination
  17. Novel digital droplet inverse PCR assay shows that natural clearance of hepatitis B infection is associated with fewer viral integrations
  18. HBV‐Induced Carcinogenesis: Mechanisms, Correlation With Viral Suppression, and Implications for Treatment
  19. Perspectives of People Living With Chronic Hepatitis D: Impact of Disease and Unmet Needs Along the Care Cascade
  20. Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis
  21. Major open questions in the hepatitis B and D field – Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop
  22. Hepatitis B discrimination: global responses requiring global data
  23. Peer support for people living with hepatitis B virus—A foundation for treatment expansion
  24. Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus
  25. Quality of life of people living with chronic hepatitis B: The role of social support system
  26. Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis
  27. Inhibition of Cellular Factor TM6SF2 Suppresses Secretion Pathways of Hepatitis B, Hepatitis C, and Hepatitis D Viruses
  28. Reply to Piewbang et al. Domestic Cat Hepadnavirus Antigens in Lymphoma Tissues. Comment on “Beatty et al. Domestic Cat Hepadnavirus and Lymphoma. Viruses 2023, 15, 2294”
  29. Domestic Cat Hepadnavirus and Pathogenic Retroviruses; A Sero-Molecular Survey of Cats in Santiago, Chile
  30. Letter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?
  31. Domestic Cat Hepadnavirus and Lymphoma
  32. Special Issue “Hepatitis B Virus: New Breakthroughs to Conquer an Ancient Disease”
  33. Targeting Hepatitis B Virus DNA Using Designer Gene Editors
  34. Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B
  35. Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”
  36. Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”
  37. Targeting liver metabolism: a pathway to cure hepatitis B virus?
  38. Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”
  39. Pathway to global elimination of hepatitis B: HBV cure is just the first step
  40. Inhibition of cellular factor TM6SF2 suppresses secretion pathways of Hepatitis B, Hepatitis C and Hepatitis D viruses
  41. Domestic Cat Hepadnavirus: Molecular Epidemiology and Phylogeny in Cats in Hong Kong
  42. Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus
  43. Prevalence and Genomic Sequence Analysis of Domestic Cat Hepadnavirus in the United States
  44. Mitosis of hepatitis B virus-infected cells in vitro results in uninfected daughter cells
  45. Stigma: a major barrier to hepatitis B elimination
  46. Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity
  47. Surrogate Markers for Hepatitis B Virus Covalently Closed Circular DNA
  48. Approaches to quantifying hepatitis B virus covalently closed circular DNA
  49. Viral integrations in chronic hepatitis B infection: Purposeless passenger or problematic promoter of persistence?
  50. A River From the Liver: Detecting Hepatocyte Genomic DNA in Urine
  51. The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research—Lessons in Scientific Community Outreach
  52. Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence
  53. De novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA
  54. Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence
  55. A sensitive and Specific PCR-based Assay to Quantify Hepatitis B Virus Covalently Closed Circular (ccc) DNA While Preserving Cellular DNA
  56. Special Issue “Hepatitis B Virus Infection: From Diagnostics to Treatments”
  57. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance
  58. The evolution and clinical impact of hepatitis B virus genome diversity
  59. The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure
  60. Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver
  61. Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus
  62. Analyse chromosomal integrierter HBV-DNA durch inverse nested PCR
  63. Journal Watch: Dr Tu looks back at the most important research articles released in 2018 relating to models and biomarkers of hepatocellular carcinoma
  64. Hepatitis B virus (HBV) DNA integration is not driven by viral proteins
  65. Detection of Low Copy Number Integrated Viral DNA Formed by <em>In Vitro</em> Hepatitis B Infection
  66. Detection of Low Copy Number Integrated Viral DNA Formed by <em>In Vitro</em> Hepatitis B Infection
  67. Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion
  68. Cellular Genomic Sites of Hepatitis B Virus DNA Integration
  69. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
  70. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
  71. Hepatitis B virus integration into cellular genome
  72. HBV bypasses the innate immune system and does not protect HCV against the antiviral effect of IFN
  73. HBV DNA Integration: Molecular Mechanisms and Clinical Implications
  74. Chronic viral hepatitis and its association with liver cancer
  75. Integrated analysis of exosomal microRNA, gene, and pathway regulatory networks in fibrosis and hepatocarcinogenesis
  76. Viral Hepatitis
  77. Whole genome sequencing analysis of familial primary sclerosing cholangitis
  78. Detection of Hepatocyte Clones Containing Integrated Hepatitis B Virus DNA Using Inverse Nested PCR
  79. Basic Science Liver
  80. Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma
  81. Abstracts of the 25th Annual Conference of APASL, February 20–24, 2016, Tokyo, Japan
  82. Differential Microrna Expression in Plasma Microvesicles Predict Hepatocellular Carcinoma Regulatory Pathways
  83. Multi-Omics Landscape of Precancerous Liver Disease
  84. Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?
  85. Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays
  86. Basic Science - Liver
  87. P0268 : Accumulation of deleterious passenger mutations during liver injury progression to hepatocellular carcinoma
  88. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma
  89. Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection
  90. Our experts highlight the most important research articles across the spectrum of topics relevant to the field of hepatic oncology
  91. Poster Presentation Abstracts
  92. Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis
  93. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
  94. Advances in and the future of treatments for hepatitis C
  95. Endoscopy Upper
  96. “Testing your methyl”: DNA methylation profiling of serum DNA of HCC patients